Gene Name |
QKI, KH domain containing, RNA binding |
heterogeneous nuclear ribonucleoprotein H2 (H) |
Image |
|
|
Gene Ontology Annotations |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
|
Diseases |
|
|
GWAS |
- Response to TNF antagonist treatment ( 18615156)
|
|
Protein-Protein Interactions |
34 interactors:
APP
ATXN1
C10orf10
CARM1
DAZ1
DAZ4
FUBP3
HCLS1
HNRNPH2
HNRNPK
HNRNPLL
IL7R
NABP1
PCBP1
PCBP2
PCBP4
PRMT1
PSMF1
PTBP1
PTBP2
RALY
RBFOX1
RBFOX2
RBM11
RBM14
RBM23
RBPMS
RNF138
SERF2
SNRPA
THAP1
U2AF2
USH1C
WDR77
|
20 interactors:
DDX5
GNB2L1
HNRNPA0
HNRNPUL1
ILF3
MSI2
PQBP1
PRMT6
PRPF31
PRPF8
QKI
RAD21
RBFOX2
RBM10
RBM39
RBM4
SF1
SNRPC
TEKT1
WDR83
|
Entrez ID |
9444 |
3188 |
HPRD ID |
06691 |
03022 |
Ensembl ID |
ENSG00000112531
|
ENSG00000126945
|
Uniprot IDs |
Q8WY44
Q96PU8
|
P55795
|
PDB IDs |
4JVH
|
1WEZ
1WG5
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
activate
cal
cancers
clarify
contribute
currently
cyclin
d1
frequently
malignancies
mapk
mitogen
modulating
newly
occurring
occurs
oral
oscc
quaking
regulative
resulting
shows
squamous
suppressor
tumour
uncontrolled
underexpression
unknown
world
|
|
Tagcloud (Difference) ? |
activate
cal
cancers
clarify
contribute
currently
cyclin
d1
frequently
malignancies
mapk
mitogen
modulating
newly
occurring
occurs
oral
oscc
quaking
regulative
resulting
shows
squamous
suppressor
tumour
uncontrolled
underexpression
unknown
world
|
|
Tagcloud (Intersection) ? |
|